Cargando…

Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis

OBJECTIVES: Chronic rhinosinusitis and nasal polyposis are common conditions in cystic fibrosis (CF). Approximately 2–3% of pediatric CF patients per year have sinus disease requiring surgery. It has been well established that there is a significant negative impact on quality of life associated with...

Descripción completa

Detalles Bibliográficos
Autor principal: Virgin, Frank W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655562/
https://www.ncbi.nlm.nih.gov/pubmed/29094071
http://dx.doi.org/10.1002/lio2.78
_version_ 1783273553853939712
author Virgin, Frank W.
author_facet Virgin, Frank W.
author_sort Virgin, Frank W.
collection PubMed
description OBJECTIVES: Chronic rhinosinusitis and nasal polyposis are common conditions in cystic fibrosis (CF). Approximately 2–3% of pediatric CF patients per year have sinus disease requiring surgery. It has been well established that there is a significant negative impact on quality of life associated with chronic rhinosinusitis (CRS) in the non‐CF patient population. However, the impact of CRS on the pediatric CF population remains uncertain. The purpose of this article is to review the current state of outcome measures for CRS in pediatric CF patients. DATA SOURCES: PubMed and EMBASE literature review METHODS: PubMed and EMBASE electronic databases were searched using Boolean searches that incorporated mesh headings and plain language for quality of life, symptom evaluation, pediatric patients, and sinusitis/rhinosinusitis. Studies were included if the study primarily evaluated a pediatric Cystic Fibrosis‐Chronic Rhinosinusitis (CF‐CRS) population and the primary outcome measure was quality of life evaluation. RESULTS: The search yielded 34 unique articles. A total of 7 articles met inclusion criteria CONCLUSIONS: Despite the high frequency of chronic rhinosinusitis in the pediatric CF patient population, its impact on quality of life is not well understood. Currently there is a lack of a validated disease specific quality of life instruments available to assess the impact of CRS on the pediatric CF patient population. LEVEL OF EVIDENCE: 5.
format Online
Article
Text
id pubmed-5655562
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56555622017-11-01 Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis Virgin, Frank W. Laryngoscope Investig Otolaryngol Allergy, Rhinology, and Immunology OBJECTIVES: Chronic rhinosinusitis and nasal polyposis are common conditions in cystic fibrosis (CF). Approximately 2–3% of pediatric CF patients per year have sinus disease requiring surgery. It has been well established that there is a significant negative impact on quality of life associated with chronic rhinosinusitis (CRS) in the non‐CF patient population. However, the impact of CRS on the pediatric CF population remains uncertain. The purpose of this article is to review the current state of outcome measures for CRS in pediatric CF patients. DATA SOURCES: PubMed and EMBASE literature review METHODS: PubMed and EMBASE electronic databases were searched using Boolean searches that incorporated mesh headings and plain language for quality of life, symptom evaluation, pediatric patients, and sinusitis/rhinosinusitis. Studies were included if the study primarily evaluated a pediatric Cystic Fibrosis‐Chronic Rhinosinusitis (CF‐CRS) population and the primary outcome measure was quality of life evaluation. RESULTS: The search yielded 34 unique articles. A total of 7 articles met inclusion criteria CONCLUSIONS: Despite the high frequency of chronic rhinosinusitis in the pediatric CF patient population, its impact on quality of life is not well understood. Currently there is a lack of a validated disease specific quality of life instruments available to assess the impact of CRS on the pediatric CF patient population. LEVEL OF EVIDENCE: 5. John Wiley and Sons Inc. 2017-05-31 /pmc/articles/PMC5655562/ /pubmed/29094071 http://dx.doi.org/10.1002/lio2.78 Text en © 2017 The Authors Laryngoscope Investigative Otolaryngology published by Wiley Periodicals, Inc. on behalf of The Triological Society This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Allergy, Rhinology, and Immunology
Virgin, Frank W.
Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis
title Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis
title_full Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis
title_fullStr Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis
title_full_unstemmed Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis
title_short Clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis
title_sort clinical chronic rhinosinusitis outcomes in pediatric patients with cystic fibrosis
topic Allergy, Rhinology, and Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655562/
https://www.ncbi.nlm.nih.gov/pubmed/29094071
http://dx.doi.org/10.1002/lio2.78
work_keys_str_mv AT virginfrankw clinicalchronicrhinosinusitisoutcomesinpediatricpatientswithcysticfibrosis